BPG is committed to discovery and dissemination of knowledge
Featured Articles
2/11/2015 8:58:00 AM | Browse: 827 | Download: 1790
Publication Name World Journal of Clinical Infectious Diseases
Manuscript ID 12741
Country Spain
ISSN 2220-3176 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/ licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Infectious Diseases
Manuscript Type Minireviews
Article Title Pneumococcal disease in adult solid organ transplantationrecipients
Manuscript Source Invited Manuscript
All Author List Cristina Roca-Oporto, María Eugenia Pachón-Ibañez, Jerónimo Pachón and Elisa Cordero
Funding Agency and Grant Number
Funding Agency Grant Number
Ministerio de Economíay Competitividad
European Development Regional Fund
Spanish Network for the Research in Infectious Diseases REIPI RD12/00015/0001
Corresponding Author efficacy is variable. Booster strategy with 7-valent pneumococcal conjugate vaccine has not shown benefit in this population. Despite its relevance, robust evidence on pneumococcal disease in organ transplant recipients is lacking. New strategies for improving the protection of SOT recipients are warranted.
Key Words Transplantation; Pneumococcal infections; Pneumococcal serotypes; Nasopharyngeal carriage; Pneumococcal vaccine
Core Tip Streptococcus pneumoniae causes substantial morbidity and mortality in solid organ transplant (SOT) recipients, ranging from non-invasive to invasive diseases, with a 12-fold risk of invasive pneumococcal disease higher than in non-immunocompromised patients. Pneumococcal vaccination is recommended for all SOT recipients with 23-valent pneumococcal polysaccharides vaccine. Although immunological rate response is appropriate, it is lower than in the rest of the population, decreases with time, and its clinical efficacy is variable. Booster strategy with 7-valent pneumococcal conjugate vaccine has not shown benefit in this population. Despite its relevance, robust evidence on pneumococcal disease in organ transplant recipients is lacking. New strategies for improving the protection of SOT recipients are warranted.
Publish Date 2015-02-05 14:02
Citation Roca-Oporto C, Pachón-Ibañez ME, Pachón J, Cordero E. Pneumococcal disease in adult solid organ transplantation recipients. World J Clin Infect Dis 2015; 5(1): 1-10
URL http://www.wjgnet.com/2220-3176/full/v5/i1/1.htm
DOI http://dx.doi.org/10.5495/wjcid.v5.i1.1
Full Article (PDF) WJCID-5-1.pdf
Full Article (Word) WJCID-5-1.doc